Browse by ["viewname_eprint_publisher" not defined]
![]() | Up a level |
- University of Regensburg (3)
- Medicine (3)
- Zentren des Universitätsklinikums Regensburg (3)
- Zentrum für Hirntumore (ZHT) (3)
- Zentren des Universitätsklinikums Regensburg (3)
- Medicine (3)
G
Glas, M. and Scheffler, B. and Lazaridis, L. and Herrlinger, U. and Pierscianek, D. and El Hindy, N. and Sure, U. and Proescholdt, M. and Hau, P. and Hense, J. and Kleinschnitz, C. and Combs, S. E. and Grosu, A. -L. and Stuschke, M. and Kebir, S. (2018) PriCoTTF: A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma. SPRINGER HEIDELBERG, HEIDELBERG.
Guberina, N. and Poettgen, C. and Kebir, S. and Lazaridis, L. and Scharmberg, C. and Luedemann, L. and Niessen, M. and Guberina, M. and Scheffler, B. and Jendrossek, V and Jabbarli, R. and Pierscianek, D. and Sure, U. and Schmidt, T. and Oster, C. and Hau, P. and Grosu, A. and Stuschke, M. and Glas, M. and Nour, Y. and Luebcke, W. (2020) Evaluation of the dosimetric Effects of geometric Variation of Tumor Treating Field (TTF) Electrode Positioning in the PriCoTTF Phase I/II Study. In: 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), 2020, Wiesbaden, GERMANY.
H
Hoffmann, Johannes and Hau, Peter and Pukrop, Tobias and Karthaus, Meinolf (2019) Drug treatment of gliomas. ONKOLOGE, 25 (1). pp. 53-59. ISSN 0947-8965, 1433-0415

